Rajan Sharma

Stock Analyst at Goldman Sachs

(0.41)

# 3,896

Out of 4,792 analysts

4

Total ratings

33.33%

Success rate

-13.26%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

Stocks Rated by Rajan Sharma

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AZN AstraZeneca	Initiates: Buy	$97	$73.92	+31.22%	1	May 30, 2024
	GSK GSK plc	Initiates: Neutral	$47	$39.01	+20.48%	1	May 30, 2024
	IMCR Immunocore Holdings	Reiterates: Overweight	$79	$29.04	+172.04%	2	Jun 20, 2023

AstraZeneca

May 30, 2024

Initiates: Buy

Price Target: $97

Current: $73.92

Upside: +31.22%

GSK plc

May 30, 2024

Initiates: Neutral

Price Target: $47

Current: $39.01

Upside: +20.48%

Immunocore Holdings

Jun 20, 2023

Reiterates: Overweight

Price Target: $79

Current: $29.04

Upside: +172.04%